Interstitial Lung Disease clinical trials at UCSD

1 in progress, 0 open to eligible people

Showing trials for

  • Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

    Sorry, in progress, not accepting new patients

    Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from baseline to Week 52.

    La Jolla, California and other locations

Last updated: